Addex to present at the sachs associates 22nd annual biotech in europe forum & baader investment conference

Geneva, switzerland, september 20, 2022 - addex therapeutics (six and nasdaq: adxn), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that ceo, tim dyer will present at both the sachs associates 22nd annual biotech in europe forum in basel, switzerland and the baader investment conference in munich, germany taking place september 21 - 22, 2022 and september 23, 2022, respectively.
ADXN Ratings Summary
ADXN Quant Ranking